Journal article
135La as an auger-electron emitter for targeted internal radiotherapy
Introduction: 135La has favorable nuclear and chemical properties for Auger-based targeted internal radiotherapy. Here we present detailed investigations of the production, emissions, imaging characteristics, and dosimetry related to 135La therapy. Methods and Results: 135La was produced by 16.5 MeV proton irradiation of metallic natBa on a medical cyclotron, and was isolated and purified by trap-and-release on weak cation-exchange resin.
The average production rate was 407 ± 19 MBq/µA (saturation activity, n = 3), and the radionuclidic purity was 98% at 20 h post irradiation. Chemical separation recovered > 98 % of the 135La with an effective molar activity of 70 ±20 GBq/µmol. To better assess cellular and organ dosimetry of this nuclide, we have recalculated the X-ray and Auger emission spectra using a Monte Carlo model accounting for effects of multiple vacancies during the Auger cascade.
The generated Auger spectrum was used to recalculate cellular S-factors. Conclusion: 135La was produced with high specific activity, reactivity, radionuclidic purity, and yield. The emission spectrum and the dosimetry are favorable for internal radionuclide therapy. .
Language: | English |
---|---|
Year: | 2018 |
Pages: | 015026 |
ISSN: | 13616560 and 00319155 |
Types: | Journal article |
DOI: | 10.1088/1361-6560/aa9b44 |
ORCIDs: | Fonslet, Jesper , Jensen, Mikael , Severin, Gregory , 0000-0003-2081-5103 and 0000-0002-4028-1404 |